Drugs List

Drugs A-Z List - I
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs List [Browse by brand or generic name]
Ibrance palbociclib) Capsules for Oral Administration - FDA

Description : IBRANCE capsules for oral administration contain 125 mg, 100 mg, or 75 mg of palbociclib, a...

  • Indications
  • IBRANCE is indicated in combination with letrozole for the treatment of postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2
  •   Read More
Ibudone, Reprexain, Vicoprofen hydrocodone and ibuprofen (Pronunciation: hye dro - FDA

Description : Each VICOPROFEN (hydrocodone and ibuprofen) tablet contains: Hydrocodone Bitartrate, USP 7.5 m...

  • Indications
  • Carefully consider the potential benefits and risks of VICOPROFEN (hydrocodone and ibuprofen) and other treatment options before deciding to use VICOPROFEN (hydrocodone and ib
  •   Read More
Ibudone, Reprexain, Vicoprofen hydrocodone and ibuprofen (Pronunciation: hye dro - Multum

Description : Each VICOPROFEN (hydrocodone and ibuprofen) tablet contains: Hydrocodone Bitartrate, USP 7.5 m...

  • Indications
  • Carefully consider the potential benefits and risks of VICOPROFEN (hydrocodone and ibuprofen) and other treatment options before deciding to use VICOPROFEN (hydrocodone and ib
  •   Read More
Ic-Green (Indocyanine Green for Injection, USP) Sterile - FDA

Description : IC-GREEN™ (tricarbocyanine) is a sterile, lyophilized green powder containing 25 mg o...

  • Indications
  • For determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography.
  •   Read More
Iclusig ponatinib (Pronunciation: poe NA ti nib) - FDA

Description : Iclusig (ponatinib) is a kinase inhibitor. The chemical name for ponatinib hydrochloride is...

  • Indications
  • Iclusig (ponatinib) is a kinase inhibitor. The chemical name for ponatinib hydrochloride is 3-(imidazo[1,2-b]pyridazin-3ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)m
  •   Read More
Iclusig ponatinib (Pronunciation: poe NA ti nib) - Multum

Description : Iclusig (ponatinib) is a kinase inhibitor. The chemical name for ponatinib hydrochloride is...

  • Indications
  • Iclusig (ponatinib) is a kinase inhibitor indicated for the: Treatment of adult patients with T315I-positive chronic myeloid leukemia (CML) (chronic phase, accelerated
  •   Read More
Iclusig ponatinib (Pronunciation: poe NA ti nib) - FDA

Description : Iclusig (ponatinib) is a kinase inhibitor. The chemical name for ponatinib hydrochloride is...

  • Indications
  • Iclusig (ponatinib) is a kinase inhibitor indicated for the: Treatment of adult patients with T315I-positive chronic myeloid leukemia (CML) (chronic phase, accelerated
  •   Read More
Iclusig ponatinib (Pronunciation: poe NA ti nib) - Multum

Description : Iclusig (ponatinib) is a kinase inhibitor. The chemical name for ponatinib hydrochloride is...

  • Indications
  • Iclusig (ponatinib) is a kinase inhibitor indicated for the: Treatment of adult patients with T315I-positive chronic myeloid leukemia (CML) (chronic phase, accelerated
  •   Read More
Idamycin idarubicin hydrochloride) for Injection, USP - FDA

Description : IDAMYCIN® (idarubicin hydrochloride for injection, USP) is a sterile, semi-synthetic an...

  • Indications
  • IDAMYCIN (idarubicin hydrochloride for injection, USP) in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in
  •   Read More
Idamycin (idarubicin hydrochloride) for Injection, USP - FDA

Description : IDAMYCIN® (idarubicin hydrochloride for injection, USP) is a sterile, semi-synthetic an...

  • Indications
  • IDAMYCIN (idarubicin hydrochloride for injection, USP) in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML) in
  •   Read More
Idamycin PFS idarubicin (Pronunciation: EYE da ROO bi sin) - FDA

Description : IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile, semi-synthetic, ...

  • Indications
  • IDAMYCIN PFS (idarubicin hydrochloride injection) Injection in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML
  •   Read More
Idamycin PFS idarubicin (Pronunciation: EYE da ROO bi sin - Multum

Description : IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile, semi-synthetic, ...

  • Indications
  • IDAMYCIN PFS (idarubicin hydrochloride injection) Injection in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML
  •   Read More
Idamycin PFS idarubicin (Pronunciation: EYE da ROO bi sin) - FDA

Description : IDAMYCIN PFS Injection contains idarubicin hydrochloride and is a sterile, semi-synthetic, ...

  • Indications
  • IDAMYCIN PFS (idarubicin hydrochloride injection) Injection in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia (AML
  •   Read More
Ifex  ifosfamide (Pronunciation: eye FOS fah mide - Multum

Description : IFEX (ifosfamide for injection, USP) single-dose vials for constitution and administration ...

  • Indications
  • IFEX (ifosfamide) , used in combination with certain other approved antineoplastic agents, is indicated for third line chemotherapy of germ cell testicular cancer. It should b
  •   Read More
Ifex  ifosfamide (Pronunciation: eye FOS fah mide) - FDA

Description : IFEX (ifosfamide for injection, USP) single-dose vials for constitution and administration ...

  • Indications
  • IFEX (ifosfamide) , used in combination with certain other approved antineoplastic agents, is indicated for third line chemotherapy of germ cell testicular cancer. It should b
  •   Read More
Ifex  ifosfamide (Pronunciation: eye FOS fah mide) - FDA

Description : IFEX (ifosfamide for injection, USP) single-dose vials for constitution and administration ...

  • Indications
  • IFEX (ifosfamide) , used in combination with certain other approved antineoplastic agents, is indicated for third line chemotherapy of germ cell testicular cancer. It should b
  •   Read More
Ifex  ifosfamide (Pronunciation: eye FOS fah mide) - Multum

Description : IFEX (ifosfamide for injection, USP) single-dose vials for constitution and administration ...

  • Indications
  • IFEX (ifosfamide) , used in combination with certain other approved antineoplastic agents, is indicated for third line chemotherapy of germ cell testicular cancer. It should b
  •   Read More
Ilaris canakinumab (Pronunciation: KAN a KIN ue mab) - FDA

Description : Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs...

  • Indications
  • Cryopyrin-Associated Periodic Syndromes (CAPS) ILARIS (canakinumab) is an interleukin-1β blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndro
  •   Read More
Ilaris canakinumab (Pronunciation: KAN a KIN ue mab) - Multum

Description : Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs...

  • Indications
  • Cryopyrin-Associated Periodic Syndromes (CAPS) ILARIS (canakinumab) is an interleukin-1β blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndro
  •   Read More
Ilaris canakinumab (Pronunciation: KAN a KIN ue mab - Multum

Description : Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs...

  • Indications
  • Cryopyrin-Associated Periodic Syndromes (CAPS) ILARIS (canakinumab) is an interleukin-1β blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndro
  •   Read More
Ilaris canakinumab (Pronunciation: KAN a KIN ue mab - Multum

Description : Canakinumab is a recombinant, human anti-human-IL-1β monoclonal antibody that belongs...

  • Indications
  • Cryopyrin-Associated Periodic Syndromes (CAPS) ILARIS (canakinumab) is an interleukin-1β blocker indicated for the treatment of Cryopyrin-Associated Periodic Syndro
  •   Read More
Ilevro (nepafenac) Ophthalmic Suspension - FDA

Description : ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is a sterile, topical, nonsteroidal a...

  • Indications
  • ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery.
  •   Read More
Ilevro (nepafenac) Ophthalmic Suspension - FDA

Description : ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is a sterile, topical, nonsteroidal a...

  • Indications
  • ILEVRO™ (nepafenac ophthalmic suspension), 0.3% is indicated for the treatment of pain and inflammation associated with cataract surgery.
  •   Read More
Ilotycin (erythromycin) Ointment - FDA

Description : ILOTYCIN™ Erythromycin Ophthalmic Ointment belongs to the macrolide group of an...

  • Indications
  • For the treatment of superficial ocular infections involving the conjunctiva and/orcornea caused by organisms susceptible to erythromycin. For prophy
  •   Read More
Ilotycin erythromycin) Ointment - FDA

Description : ILOTYCIN™ Erythromycin Ophthalmic Ointment belongs to the macrolide group of antibiot...

  • Indications
  • For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For prophylaxis of ophthalmia
  •   Read More
Iluvien (fluocinolone acetonide) Intravitreal Implant - FDA

Description : ILUVIEN is a sterile non-bioerodable intravitreal implant containing 0.19 mg (190 mcg) fluo...

  • Indications
  • ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema in patients who have been previously treated w
  •   Read More
Iluvien fluocinolone acetonide) Intravitreal Implant - FDA

Description : ILUVIEN is a sterile non-bioerodable intravitreal implant containing 0.19 mg (190 mcg) fluo...

  • Indications
  • ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg is indicated for the treatment of diabetic macular edema in patients who have been previously treated with
  •   Read More
Imbruvica ibrutinib) Capsules for Oral Administration - FDA

Description : Ibrutinib is an inhibitor of Bruton's tyrosine kinase (BTK). It is a white to off-white sol...

  • Indications
  • Mantle Cell Lymphoma IMBRUVICA is indicated for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Accelerated appro
  •   Read More
Imbruvica (ibrutinib) Capsules for Oral Administration - FDA

Description : Ibrutinib is an inhibitor of Bruton's tyrosine kinase (BTK). It is a white to off-white sol...

  • Indications
  • Mantle Cell Lymphoma IMBRUVICA is indicated for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Accelerated appro
  •   Read More
Imdur, ISMO, Monoket isosorbide mononitrate (Pronunciation: EYE soe SOR - FDA

Description : Isosorbide mononitrate is 1,4:3,6-dianhydro-D-glucitol, 5-nitrate, an organic nitrate whose...

  • Indications
  • Ismo (isosorbide mononitrate) tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is
  •   Read More
Imdur, ISMO, Monoket  isosorbide mononitrate (Pronunciation: EYE soe SO - Multum

Description : Isosorbide mononitrate is 1,4:3,6-dianhydro-D-glucitol, 5-nitrate, an organic nitrate whose...

  • Indications
  • Ismo (isosorbide mononitrate) tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is
  •   Read More
Imdur, ISMO, Monoket isosorbide mononitrate (Pronunciation: EYE soe SOR - FDA

Description : Isosorbide mononitrate is 1,4:3,6-dianhydro-D-glucitol, 5-nitrate, an organic nitrate whose...

  • Indications
  • Ismo (isosorbide mononitrate) tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral isosorbide mononitrate is
  •   Read More
Imitrex, Imitrex Nasal  sumatriptan (oral/nasal) (Pronunciation: soo ma T - FDA

Description : IMITREX Tablets contain sumatriptan succinate, a selective 5-HT1B/1D receptor agonist. Suma...

  • Indications
  • IMITREX® Tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations Of Use Use only if a clear diagnosis of migraine he
  •   Read More
Imitrex, Imitrex Nasal sumatriptan (oral/nasal) (Pronunciation: soo ma TR - Multum

Description : IMITREX Tablets contain sumatriptan succinate, a selective 5-HT1B/1D receptor agonist. Suma...

  • Indications
  • IMITREX® Tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations Of Use Use only if a clear diagnosis of migraine he
  •   Read More
Imitrex, Imitrex Nasal  sumatriptan (oral/nasal) (Pronunciation: soo ma T - FDA

Description : IMITREX (sumatriptan) Nasal Spray contains sumatriptan, a selective 5-hydroxytryptamine1 re...

  • Indications
  • IMITREX Nasal Spray (sumatriptan nasal spray) is indicated for the acute treatment of migraine attacks with or without aura in adults. IMITREX Nasal Spray (sumatriptan na
  •   Read More
Imitrex, Imitrex Nasal  sumatriptan (oral/nasal) (Pronunciation: soo ma T - FDA

Description : IMITREX (sumatriptan) Nasal Spray contains sumatriptan, a selective 5-hydroxytryptamine1 recept...

  • Indications
  • IMITREX Nasal Spray (sumatriptan nasal spray) is indicated for the acute treatment of migraine attacks with or without aura in adults. IMITREX Nasal Spray (sumatriptan na
  •   Read More
Imitrex, Imitrex Nasal  sumatriptan (oral/nasal) (Pronunciation: soo ma T - Multum

Description : What is sumatriptan (Imitrex Nasal Spray)? Sumatriptan is a headache medicine that narrows blo...

  • Indications
  • IMITREX Nasal Spray (sumatriptan nasal spray) is indicated for the acute treatment of migraine attacks with or without aura in adults. IMITREX Nasal Spray (sumatriptan na
  •   Read More
Imogam Rabies Rabies Immune Globulin (human), USP - FDA

Description : Rabies Immune Globulin (Human) USP, Imogam® Rabies – HT (rabies immune globulin h...

  • Indications
  • Rabies Immune Globulin (Human), Imogam® Rabies - HT (rabies immune globulin (human)) , is indicated for individuals suspected of exposure to rabies, particularly severe ex
  •   Read More
Imogam Rabies Rabies Immune Globulin (human), USP - FDA

Description : Rabies Immune Globulin (Human) USP, Imogam® Rabies – HT (rabies immune globulin h...

  • Indications
  • Rabies Immune Globulin (Human), Imogam® Rabies - HT (rabies immune globulin (human)) , is indicated for individuals suspected of exposure to rabies, particularly sever
  •   Read More
Imovax Rabies rabies vaccine (human diploid cell) (Pronunciation - FDA

Description : The Imovax Rabies Vaccine produced by Sanofi Pasteur SA is a sterile, stable, freeze-dried ...

  • Indications
  • Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups. Rationale Of
  •   Read More
Imovax Rabies rabies vaccine (human diploid cell) (Pronunciation - Multum

Description : The Imovax Rabies Vaccine produced by Sanofi Pasteur SA is a sterile, stable, freeze-dried ...

  • Indications
  • Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups. Rationale Of
  •   Read More
Imovax Rabies rabies vaccine (human diploid cell) (Pronunciation - FDA

Description : The Imovax Rabies Vaccine produced by Sanofi Pasteur SA is a sterile, stable, freeze-dried ...

  • Indications
  • Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups. Rational
  •   Read More
Imovax Rabies rabies vaccine (human diploid cell) (Pronunciation - Multum

Description : The Imovax Rabies Vaccine produced by Sanofi Pasteur SA is a sterile, stable, freeze-dried ...

  • Indications
  • Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups. Rational
  •   Read More
Impavido miltefosine) Capsules - FDA

Description : IMPAVIDO capsules contain the active ingredient miltefosine, an antileishmanial agent. The ...

  • Indications
  • IMPAVIDO (miltefosine) capsules are indicated in adults and adolescents ≥ 12 years of age weighing ≥ 30 kg for the treatment of: Visceral leishmaniasis caused by
  •   Read More
Impavido (miltefosine) Capsules - FDA

Description : IMPAVIDO capsules contain the active ingredient miltefosine, an antileishmanial agent. The chem...

  • Indications
  • IMPAVIDO (miltefosine) capsules are indicated in adults and adolescents ≥ 12 years of age weighing ≥ 30 kg for the treatment of: Visceral leishmaniasis caused by
  •   Read More
Implanon, Nexplanon etonogestrel (implant) (Pronunciation: e toe noe J - FDA

Description : IMPLANON (etonogestrel implant) is a progestin-only, soft, flexible implant preloaded in a...

  • Indications
  • IMPLANON® is indicated for use by women to prevent pregnancy.
  •   Read More
Implanon, Nexplanon etonogestrel (implant) (Pronunciation: e toe noe J - Multum

Description : IMPLANON (etonogestrel implant) is a progestin-only, soft, flexible implant preloaded in a...

  • Indications
  • IMPLANON® is indicated for use by women to prevent pregnancy.
  •   Read More
In-111 Zevalin, Y-90 Zevalin ibritumomab (Pronunciation: ib ri TYOO mo mab) - Multum

Description : Zevalin (ibritumomab tiuxetan) is the immunoconjugate resulting from a stable thiourea cova...

  • Indications
  • Relapsed or Refractory, Low-grade or Follicular NHL Zevalin is indicated for the treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphom
  •   Read More
In-111 Zevalin, Y-90 Zevalin ibritumomab (Pronunciation: ib ri TYOO mo mab) - FDA

Description : Zevalin (ibritumomab tiuxetan) is the immunoconjugate resulting from a stable thiourea covalent...

  • Indications
  • Relapsed or Refractory, Low-grade or Follicular NHL Zevalin is indicated for the treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphom
  •   Read More
In-111 Zevalin, Y-90 Zevalin ibritumomab (Pronunciation: ib ri TYOO mo mab) - Multum

Description : Zevalin (ibritumomab tiuxetan) is the immunoconjugate resulting from a stable thiourea covalent...

  • Indications
  • Relapsed or Refractory, Low-grade or Follicular NHL Zevalin is indicated for the treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin's lymphom
  •   Read More
Inapsine droperidol (Pronunciation: dro PER i dol) - FDA

Description : INAPSINE contains droperidol, a neuroleptic (tranquilizer) agent. Inapsine (droperidol) Inj...

  • Indications
  • INAPSINE (droperidol) is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.
  •   Read More
Inapsine droperidol (Pronunciation: dro PER i dol) - Multum

Description : INAPSINE contains droperidol, a neuroleptic (tranquilizer) agent. Inapsine (droperidol) Inj...

  • Indications
  • INAPSINE (droperidol) is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.
  •   Read More
Inapsine droperidol (Pronunciation: dro PER i dol - Multum

Description : INAPSINE contains droperidol, a neuroleptic (tranquilizer) agent. Inapsine (droperidol) Inj...

  • Indications
  • INAPSINE (droperidol) is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures.
  •   Read More
Incivek telaprevir (Pronunciation: tel A pre vir) - Multum

Description : INCIVEK (telaprevir) is an inhibitor of the HCV NS3/4A protease. The IUPAC name for telapr...

  • Indications
  • Chronic Hepatitis C INCIVEK® (telaprevir), in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype 1 chronic hepatitis C in a
  •   Read More
Incivek telaprevir) Film-Coated Tablets - FDA

Description : INCIVEK (telaprevir) is an inhibitor of the HCV NS3/4A protease. The IUPAC name for telapr...

  • Indications
  • Chronic Hepatitis C INCIVEK® (telaprevir), in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype 1 chronic hepatitis C in a
  •   Read More
Incivek  telaprevir (Pronunciation: tel A pre vir) - Multum

Description : INCIVEK (telaprevir) is an inhibitor of the HCV NS3/4A protease. The IUPAC name for telapr...

  • Indications
  • Chronic Hepatitis C INCIVEK® (telaprevir), in combination with peginterferon alfa and ribavirin, is indicated for the treatment of genotype 1 chronic hepatitis C in a
  •   Read More
Increlex mecasermin (Pronunciation: ME ka SER min) - FDA

Description : INCRELEX® (mecasermin [rDNA origin] injection) contains human insulin-like growth facto...

  • Indications
  • Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [rDNA origin] injection) is indicated for the treatment of: growth failure in children with se
  •   Read More
Increlex mecasermin (Pronunciation: ME ka SER min) - Multum

Description : INCRELEX® (mecasermin [rDNA origin] injection) contains human insulin-like growth facto...

  • Indications
  • Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [rDNA origin] injection) is indicated for the treatment of: growth failure in children with se
  •   Read More
Increlex mecasermin (Pronunciation: ME ka SER min) - FDA

Description : INCRELEX® (mecasermin [rDNA origin] injection) contains human insulin-like growth fact...

  • Indications
  • Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [rDNA origin] injection) is indicated for the treatment of: growth failure in children with severe
  •   Read More
Increlex mecasermin (Pronunciation: ME ka SER min) - Multum

Description : INCRELEX® (mecasermin [rDNA origin] injection) contains human insulin-like growth fact...

  • Indications
  • Severe Primary IGF-1 Deficiency (Primary IGFD) INCRELEX® (mecasermin [rDNA origin] injection) is indicated for the treatment of: growth failure in children with severe
  •   Read More
Incruse Ellipta umeclidinium) Inhalation Powder - FDA

Description : INCRUSE ELLIPTA contains the active ingredient umeclidinium, an anticholinergic. Umeclidin...

  • Indications
  • INCRUSE™ ELLIPTA® is an anticholinergic indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pu
  •   Read More
Incruse Ellipta (umeclidinium) Inhalation Powder - FDA

Description : INCRUSE ELLIPTA contains the active ingredient umeclidinium, an anticholinergic. Umeclidin...

  • Indications
  • INCRUSE™ ELLIPTA® is an anticholinergic indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pu
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol - Multum

Description : Inderal® (propranolol hydrochloride) is a synthetic beta-adrenergic receptor blocking a...

  • Indications
  • Hypertension Inderal is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazi
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol - FDA

Description : Inderal® (propranolol hydrochloride) is a synthetic beta-adrenergic receptor-blocking a...

  • Indications
  • Hypertension Inderal LA (propranolol) is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, part
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol) - FDA

Description : INNOPRAN XL contains propranolol hydrochloride, a nonselective, beta-adrenergic receptor-bl...

  • Indications
  • INNOPRAN XL® is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular eve
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol) - FDA

Description : Inderal® (propranolol hydrochloride) is a synthetic beta-adrenergic receptor blocking a...

  • Indications
  • Hypertension Inderal is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazi
  •   Read More
Inderal, Inderal LA, InnoPran XL  propranolol (Pronunciation: pro PRAN oh lol) - Multum

Description : Inderal® (propranolol hydrochloride) is a synthetic beta-adrenergic receptor blocking a...

  • Indications
  • Hypertension Inderal is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, particularly a thiazi
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol) - FDA

Description : Inderal® (propranolol hydrochloride) is a synthetic beta-adrenergic receptor-blocking a...

  • Indications
  • Hypertension Inderal LA (propranolol) is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, part
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol) - Multum

Description : Inderal® (propranolol hydrochloride) is a synthetic beta-adrenergic receptor-blocking a...

  • Indications
  • Hypertension Inderal LA (propranolol) is indicated in the management of hypertension. It may be used alone or used in combination with other antihypertensive agents, part
  •   Read More
Inderal, Inderal LA, InnoPran XL propranolol (Pronunciation: pro PRAN oh lol) - Multum

Description : INNOPRAN XL contains propranolol hydrochloride, a nonselective, beta-adrenergic receptor-bl...

  • Indications
  • INNOPRAN XL® is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events,
  •   Read More
Inderide hydrochlorothiazide and propranolol (Pronunciation - Multum

Description : Inderide (propranolol hydrochloride and hydrochlorothiazide) Tablets for oral administratio...

  • Indications
  • Inderide (propranolol hydrochloride and hydrochlorothiazide) is indicated in the management of hypertension. This fixed combination is not indicated for initial therapy o
  •   Read More
Inderide  hydrochlorothiazide and propranolol (Pronunciatio - FDA

Description : Inderide (propranolol hydrochloride and hydrochlorothiazide) Tablets for oral administratio...

  • Indications
  • Inderide (propranolol hydrochloride and hydrochlorothiazide) is indicated in the management of hypertension. This fixed combination is not indicated for initial therapy o
  •   Read More
Inderide  hydrochlorothiazide and propranolol (Pronunciatio - Multum

Description : Inderide (propranolol hydrochloride and hydrochlorothiazide) Tablets for oral administratio...

  • Indications
  • Inderide (propranolol hydrochloride and hydrochlorothiazide) is indicated in the management of hypertension. This fixed combination is not indicated for initial therapy o
  •   Read More
Indigo Carmine (indigotindisulfonate sodium) Injection, USP - FDA

Description : Each 5 mL contains: 40 mg of Indigotindisulfonate Sodium, in Water for Injection, q.s. pH a...

  • Indications
  • Originally employed as a kidney function test, the chief application of Indigo Carmine (indigotindisulfonate) at present is localizing ureteral orifices during cystoscopy and
  •   Read More
Indigo Carmine indigotindisulfonate sodium) Injection, USP - FDA

Description : Each 5 mL contains: 40 mg of Indigotindisulfonate Sodium, in Water for Injection, q.s. pH a...

  • Indications
  • Each 5 mL contains: 40 mg of Indigotindisulfonate Sodium, in Water for Injection, q.s. pH adjusted, when necessary, with Citric Acid and/or Sodium Citrate.Sterile, nonpyro
  •   Read More
Indocin IV  (indomethacin) for Injection Sterile - FDA

Description : Sterile INDOCIN® I.V. (indomethacin for injection) for intravenous administration is ly...

  • Indications
  • INDOCIN I.V. is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medica
  •   Read More
Indocin IV indomethacin) for Injection Sterile - FDA

Description : Sterile INDOCIN® I.V. (indomethacin for injection) for intravenous administration is ly...

  • Indications
  • INDOCIN I.V. is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual me
  •   Read More
Indocin, Indocin SR indomethacin (Pronunciation: in doe METH a sin) - FDA

Description : INDOCIN (indomethacin) * is supplied in three dosage forms. Capsules INDOCIN (indomethacin)...

  • Indications
  • Carefully consider the potential benefits and risks of INDOCIN (indomethacin) and other treatment options before deciding to use INDOCIN (indomethacin) . Use the lowest ef
  •   Read More
Indocin, Indocin SR  indomethacin (Pronunciation: in doe METH a sin) - FDA

Description : Suspension INDOCIN for oral use contains 25 mg of indomethacin per 5 mL, alcohol 1%, and so...

  • Indications
  • Carefully consider the potential benefits and risks of INDOCIN and other treatment options before deciding to use INDOCIN. Use the lowest effective dose for the shortest d
  •   Read More
Indocin, Indocin SR indomethacin (Pronunciation: in doe METH a sin) - Multum

Description : Suspension INDOCIN for oral use contains 25 mg of indomethacin per 5 mL, alcohol 1%, and so...

  • Indications
  • Carefully consider the potential benefits and risks of INDOCIN and other treatment options before deciding to use INDOCIN. Use the lowest effective dose for the shortest d
  •   Read More
Indocin, Indocin SR indomethacin (Pronunciation: in doe METH a sin) - FDA

Description : INDOCIN (indomethacin) * is supplied in three dosage forms. Capsules INDOCIN (indomethacin)...

  • Indications
  • Carefully consider the potential benefits and risks of INDOCIN (indomethacin) and other treatment options before deciding to use INDOCIN (indomethacin) . Use the lowest ef
  •   Read More
Indocin, Indocin SR indomethacin (Pronunciation: in doe METH a sin) - Multum

Description : INDOCIN (indomethacin) * is supplied in three dosage forms. Capsules INDOCIN (indomethacin)...

  • Indications
  • Carefully consider the potential benefits and risks of INDOCIN (indomethacin) and other treatment options before deciding to use INDOCIN (indomethacin) . Use the lowest ef
  •   Read More
Indocin, Indocin SR  indomethacin (Pronunciation: in doe METH a sin) - Multum

Description : Suspension INDOCIN for oral use contains 25 mg of indomethacin per 5 mL, alcohol 1%, and so...

  • Indications
  • Carefully consider the potential benefits and risks of INDOCIN and other treatment options before deciding to use INDOCIN. Use the lowest effective dose for the shortest d
  •   Read More
Infasurf calfactant (Pronunciation: kal FAK tant) - FDA

Description : Infasurf® (calfactant) Intratracheal Suspension is a sterile, non-pyrogenic lung surfac...

  • Indications
  • Infasurf (calfactant) is indicated for the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS and for the treatment (“rescue
  •   Read More
Infasurf calfactant (Pronunciation: kal FAK tant) - Multum

Description : Infasurf® (calfactant) Intratracheal Suspension is a sterile, non-pyrogenic lung surfac...

  • Indications
  • Infasurf (calfactant) is indicated for the prevention of Respiratory Distress Syndrome (RDS) in premature infants at high risk for RDS and for the treatment (“rescue
  •   Read More
Infergen interferon alfacon-1 (Pronunciation: IN ter FEER o - FDA

Description : Interferon alfacon-1 is a wholly synthetic type-I interferon. The 166-amino acid sequence o...

  • Indications
  • Chronic Hepatitis C INFERGEN® (interferon alfacon-1) is indicated for treatment of chronic hepatitis C in patients 18 years of age or older with compensated liver dis
  •   Read More
Infergen interferon alfacon-1 (Pronunciation: IN ter FEER o - Multum

Description : Interferon alfacon-1 is a wholly synthetic type-I interferon. The 166-amino acid sequence o...

  • Indications
  • Chronic Hepatitis C INFERGEN® (interferon alfacon-1) is indicated for treatment of chronic hepatitis C in patients 18 years of age or older with compensated liver dis
  •   Read More
Influenza A H1N1 Intranasal Vaccine Monovalent Vaccine Live, Intranasal - FDA

Description : Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is a live monovalent vaccine fo...

  • Indications
  • Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is indicated for the active immunization of individuals 2-49 years of age against influenza disease caused by pan
  •   Read More
Influenza A H1N1 Intranasal Vaccine Monovalent Vaccine Live, Intranasal - FDA

Description : Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is a live monovalent vaccine fo...

  • Indications
  • Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal is indicated for the active immunization of individuals 2-49 years of age against influenza disease caused by pande
  •   Read More
Influenza A H1N1 Monovalent Vaccine Influenza A (H1N1) Monovalent Vaccine - FDA

Description : Influenza A (H1N1) 2009 Monovalent Vaccine, an inactivated influenza virus vaccine, for int...

  • Indications
  • Influenza A (H1N1) 2009 Monovalent Vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza d
  •   Read More
Infuvite Adult Pharmacy Bulk Package Pharmacy Bulk Package) Vials - FDA

Description : INFUVITE ADULT (Pharmacy Bulk Package) is a sterile product consisting of 2 vials – 1...

  • Indications
  • INFUVITE ADULT (Pharmacy Bulk Package) is indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition The p
  •   Read More
Infuvite Adult Pharmacy Bulk Package (Pharmacy Bulk Package) Vials,Multiple Vitamins fo - FDA

Description : INFUVITE ADULT (Pharmacy Bulk Package) is a sterile product consisting of 2 vials – 1 eac...

  • Indications
  • INFUVITE ADULT (Pharmacy Bulk Package) is indicated for the prevention of vitamin deficiency in adults and children aged 11 and older receivingparenteral nutrition The
  •   Read More
Infuvite Pediatric Pharmacy Bulk Package (multiple vitamins) Pediatric Pharmacy Bulk Packag - FDA

Description : INFUVITE (multiple vitamins for infusion pharmacy bulk package) PEDIATRIC (PHARMACY BULK PA...

  • Indications
  • INFUVITE (multiple vitamins for infusion pharmacy bulk package) PEDIATRIC (PHARMACY BULK PACKAGE) is indicated as a daily multivitamin maintenance dosage for infants and c
  •   Read More
Infuvite Pediatric Pharmacy Bulk Package (multiple vitamins) Pediatric Pharmacy Bulk Packag - FDA

Description : INFUVITE (multiple vitamins for infusion pharmacy bulk package) PEDIATRIC (PHARMACY BULK PACKAG...

  • Indications
  • INFUVITE (multiple vitamins for infusion pharmacy bulk package)PEDIATRIC (PHARMACY BULK PACKAGE) is indicated as a daily multivitamin maintenance dosage for infants
  •   Read More
Injectafer (ferric carboxymaltose) Injection - FDA

Description : Ferric carboxymaltose, an iron replacement product, is an iron carbohydrate complex with th...

  • Indications
  • Injectafer is indicated for the treatment of iron deficiency anemia in adult patients; who have intolerance to oral iron or have had unsatisfactory response to oral iro
  •   Read More
Injectafer (ferric carboxymaltose) Injection - FDA

Description : Ferric carboxymaltose, an iron replacement product, is an iron carbohydrate complex with th...

  • Indications
  • Injectafer is indicated for the treatment of iron deficiency anemia in adult patients; who have intolerance to oral iron or have had unsatisfactory response to oral iro
  •   Read More
Inlyta  axitinib (Pronunciation: axIT i nib) - FDA

Description : INLYTA (axitinib) is a kinase inhibitor. Axitinib has the chemical name N-methyl-2-[3-((E)2...

  • Indications
  • INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
  •   Read More
Inlyta axitinib (Pronunciation: axIT i nib) - Multum

Description : INLYTA (axitinib) is a kinase inhibitor. Axitinib has the chemical name N-methyl-2-[3-((E)2...

  • Indications
  • INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
  •   Read More
Inlyta (axitinib) Film-coated Tablets Patient Inform - FDA

Description : INLYTA (axitinib) is a kinase inhibitor. Axitinib has the chemical name N-methyl-2-[3-((E)2...

  • Indications
  • INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
  •   Read More
Inlyta axitinib (Pronunciation: axIT i nib) - Multum

Description : INLYTA (axitinib) is a kinase inhibitor. Axitinib has the chemical name N-methyl-2-[3-((E)2...

  • Indications
  • INLYTA is indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of one prior systemic therapy.
  •   Read More
Innohep  tinzaparin (Pronunciation: tin ZA pa rin) - FDA

Description : INNOHEP® is a sterile solution, containing tinzaparin sodium, a low molecular weight he...

  • Indications
  • INNOHEP® (tinzaparin) is indicated for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with
  •   Read More
Innohep tinzaparin (Pronunciation: tin ZA pa rin) - FDA

Description : INNOHEP® is a sterile solution, containing tinzaparin sodium, a low molecular weight hepari...

  • Indications
  • INNOHEP® (tinzaparin) is indicated for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with
  •   Read More
Innohep tinzaparin (Pronunciation: tin ZA pa rin) - Multum

Description : INNOHEP® is a sterile solution, containing tinzaparin sodium, a low molecular weight hepari...

  • Indications
  • INNOHEP® (tinzaparin) is indicated for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with war
  •   Read More
INOmax nitric oxide (inhalation gas) (Pronunciation: NYE - FDA

Description : INOmax (nitric oxide) gas is a drug administered by inhalation. Nitric oxide, the active su...

  • Indications
  • Treatment of Hypoxic Respiratory Failure INOmax® is a vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the t
  •   Read More
INOmax nitric oxide (inhalation gas) (Pronunciation: NYE - Multum

Description : INOmax (nitric oxide) gas is a drug administered by inhalation. Nitric oxide, the active su...

  • Indications
  • Treatment of Hypoxic Respiratory Failure INOmax® is a vasodilator, which, in conjunction with ventilatory support and other appropriate agents, is indicated for the t
  •   Read More
Inspra eplerenone (Pronunciation: ep LER e none) - FDA

Description : INSPRA contains eplerenone, a blocker of aldosterone binding at the mineralocorticoid...

  • Indications
  • Patient Selection Considerations Serum potassium levels should be measured before initiating INSPRA therapy, and INSPRA should not be prescribed if serum potassium
  •   Read More
Inspra eplerenone (Pronunciation: ep LER e none) - Multum

Description : INSPRA contains eplerenone, a blocker of aldosterone binding at the mineralocorticoid...

  • Indications
  • Patient Selection Considerations Serum potassium levels should be measured before initiating INSPRA therapy, and INSPRA should not be prescribed if serum potassium
  •   Read More
Inspra eplerenone (Pronunciation: ep LER e none) - FDA

Description : INSPRA contains eplerenone, a blocker of aldosterone binding at the mineralocorticoid recep...

  • Indications
  • Patient Selection Considerations Serum potassium levels should be measured before initiating INSPRA therapy, and INSPRA should not be prescribed if serum potassium is >
  •   Read More
Intal, Intal Inhaler cromolyn sodium (inhalation) (Pronunciation: KROE - FDA

Description : The active ingredient of Intal Inhaler is cromolyn sodium, USP. It is an inhaled anti- infl...

  • Indications
  • Intal Inhaler is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a con
  •   Read More
Intal, Intal Inhaler cromolyn sodium (inhalation) (Pronunciation: KROE - Multum

Description : The active ingredient of Intal Inhaler is cromolyn sodium, USP. It is an inhaled anti- infl...

  • Indications
  • Intal Inhaler is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a con
  •   Read More
Intal, Intal Inhaler cromolyn sodium (inhalation) (Pronunciation: KROE - FDA

Description : The active ingredient of INTAL Nebulizer Solution is cromolyn sodium, USP. It is an inhaled...

  • Indications
  • INTAL is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a continuous
  •   Read More
Intal, Intal Inhaler cromolyn sodium (inhalation) (Pronunciation: KROE - Multum

Description : The active ingredient of INTAL Nebulizer Solution is cromolyn sodium, USP. It is an inhaled...

  • Indications
  • INTAL is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a continuous
  •   Read More
Intal, Intal Inhaler cromolyn sodium (inhalation) (Pronunciation: KROE - Multum

Description : The active ingredient of Intal Inhaler is cromolyn sodium, USP. It is an inhaled anti- infl...

  • Indications
  • Intal Inhaler is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a con
  •   Read More
Intal, Intal Inhaler  cromolyn sodium (inhalation) (Pronunciation: KROE - Multum

Description : The active ingredient of INTAL Nebulizer Solution is cromolyn sodium, USP. It is an inhaled...

  • Indications
  • INTAL is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a continuous
  •   Read More
Integrilin eptifibatide (Pronunciation: ep ti FYE ba tide) - FDA

Description : Eptifibatide is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des-ami...

  • Indications
  • Acute Coronary Syndrome (ACS) INTEGRILIN is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (u
  •   Read More
Integrilin eptifibatide (Pronunciation: ep ti FYE ba tide) - Multum

Description : Eptifibatide is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des-ami...

  • Indications
  • Acute Coronary Syndrome (ACS) INTEGRILIN is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (u
  •   Read More
Integrilin eptifibatide (Pronunciation: ep ti FYE ba tide - FDA

Description : Eptifibatide is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des...

  • Indications
  • Acute Coronary Syndrome (ACS) INTEGRILIN is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (unstab
  •   Read More
Integrilin  eptifibatide (Pronunciation: ep ti FYE ba tide) - Multum

Description : Eptifibatide is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des...

  • Indications
  • Acute Coronary Syndrome (ACS) INTEGRILIN is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (unstab
  •   Read More
Intelence etravirine (Pronunciation: E tra VIR een) - FDA

Description : INTELENCE® (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of huma...

  • Indications
  • INTELENCE®, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in
  •   Read More
Intelence etravirine (Pronunciation: E tra VIR een) - Multum

Description : INTELENCE® (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of huma...

  • Indications
  • INTELENCE®, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in
  •   Read More
Intelence etravirine (Pronunciation: E tra VIR een) - FDA

Description : INTELENCE® (etravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) of ...

  • Indications
  • INTELENCE®, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in antiretroviral
  •   Read More
Intralipid 10% 10% I.V. Fat Emulsion) In Excel® Container - FDA

Description : INTRALIPID® 10% (10% i.v fat emulsion) (A 10% INTRAVENOUS FAT EMULSION) IS A STERILE, N...

  • Indications
  • INTRALIPID® 10% (10% i.v fat emulsion) IS INDICATED AS A SOURCE OF CALORIES AND ESSENTIAL FATTY ACIDS FOR PATIENTS REQUIRING PARENTERAL NUTRITION FOR EXTENDED PERIODS OF T
  •   Read More
Intralipid 20% 20% I.V. Fat Emulsion) In Excel® Container - FDA

Description : INTRALIPID® 20% (20% i.v. fat emulsion) (A 20% INTRAVENOUS FAT EMULSION) IS A STERILE, ...

  • Indications
  • INTRALIPID® 20% (20% i.v. fat emulsion) IS INDICATED AS A SOURCE OF CALORIES AND ESSENTIAL FATTY ACIDS FOR PATIENTS REQUIRING PARENTERAL NUTRITION FOR EXTENDED PERIODS OF
  •   Read More
Intron A  interferon alfa-2b (Pronunciation: IN ter FEAR on - Multum

Description : INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional, or intra...

  • Indications
  • Hairy Cell Leukemia INTRON® A is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia. Malignant Melanoma INTRON A is indicated
  •   Read More
Intron A  interferon alfa-2b (Pronunciation: IN ter FEAR on - FDA

Description : INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional, or intra...

  • Indications
  • Hairy Cell Leukemia INTRON® A is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia. Malignant Melanoma INTRON A is indicated
  •   Read More
Intron A  interferon alfa-2b (Pronunciation: IN ter FEAR on - Multum

Description : INTRON® A (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional, or intra...

  • Indications
  • Hairy Cell Leukemia INTRON® A is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia. Malignant Melanoma INTRON A is indicated
  •   Read More
Intron A - Rebetol ribavirin, interferon alfa-2b, recombinant) - FDA

Description : REBETOL ® (ribavirin, interferon alfa-2b, recombinant) REBETOL is Schering Corporatio...

  • Indications
  • REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patient
  •   Read More
Intron A - Rebetol (ribavirin, interferon alfa-2b, recombinant) - FDA

Description : REBETOL ® (ribavirin, interferon alfa-2b, recombinant) REBETOL is Schering Corporatio...

  • Indications
  • REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patient
  •   Read More
Intuniv, Tenex  guanfacine (Pronunciation: GWAHN fa seen) - FDA

Description : INTUNIV® is a once-daily, extended-release formulation of guanfacine hydrochloride (HCl...

  • Indications
  • INTUNIV® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical
  •   Read More
Intuniv, Tenex guanfacine (Pronunciation: GWAHN fa seen - Multum

Description : INTUNIV® is a once-daily, extended-release formulation of guanfacine hydrochloride (HCl...

  • Indications
  • INTUNIV® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical
  •   Read More
Intuniv, Tenex guanfacine (Pronunciation: GWAHN fa seen) - Multum

Description : INTUNIV® is a once-daily, extended-release formulation of guanfacine hydrochloride (HCl...

  • Indications
  • INTUNIV® is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) as monotherapy and as adjunctive therapy to stimulant medications [see Clinical
  •   Read More
Invanz ertapenem (Pronunciation: er ta PEN em) - FDA

Description : INVANZ (Ertapenem for Injection) is a sterile, synthetic, parenteral, 1-β methyl-carbapene...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of INVANZ® and other antibacterial drugs, INVANZ should be used only to treat
  •   Read More
Invanz ertapenem (Pronunciation: er ta PEN em) - Multum

Description : INVANZ (Ertapenem for Injection) is a sterile, synthetic, parenteral, 1-β methyl-carbapene...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of INVANZ® and other antibacterial drugs, INVANZ should be used only to treat
  •   Read More
Invanz ertapenem (Pronunciation: er ta PEN em) - FDA

Description : INVANZ (Ertapenem for Injection) is a sterile, synthetic, parenteral, 1-β methyl-carba...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of INVANZ® and other antibacterial drugs, INVANZ should be used only to treat or pr
  •   Read More
Invanz  ertapenem (Pronunciation: er ta PEN em) - Multum

Description : INVANZ (Ertapenem for Injection) is a sterile, synthetic, parenteral, 1-β methyl-carba...

  • Indications
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of INVANZ® and other antibacterial drugs, INVANZ should be used only to treat or pr
  •   Read More
Invega paliperidone (Pronunciation: pal ee PER i done - FDA

Description : Paliperidone, the active ingredient in INVEGA® Extended-Release Tablets, is a psychotro...

  • Indications
  • Schizophrenia INVEGA® (paliperidone) Extended-Release Tablets are indicated for the treatment of schizophrenia [see Clinical Studies]. The efficacy of INVEGA® in
  •   Read More
Invega paliperidone (Pronunciation: pal ee PER i done) - Multum

Description : Paliperidone, the active ingredient in INVEGA® Extended-Release Tablets, is a psychotro...

  • Indications
  • Schizophrenia INVEGA® (paliperidone) Extended-Release Tablets are indicated for the treatment of schizophrenia [see Clinical Studies]. The efficacy of INVEGA® in
  •   Read More
Invega paliperidone (Pronunciation: pal ee PER i done) - FDA

Description : Paliperidone, the active ingredient in INVEGA® Extended-Release Tablets, is a psychotro...

  • Indications
  • Schizophrenia INVEGA® (paliperidone) Extended-Release Tablets are indicated for the treatment of schizophrenia [see Clinical Studies]. The efficacy of INVEGA® in
  •   Read More
Invega paliperidone (Pronunciation: pal ee PER i done) - Multum

Description : Paliperidone, the active ingredient in INVEGA® Extended-Release Tablets, is a psychotro...

  • Indications
  • Schizophrenia INVEGA® (paliperidone) Extended-Release Tablets are indicated for the treatment of schizophrenia [see Clinical Studies]. The efficacy of INVEGA® in
  •   Read More
Invega Sustenna (paliperidone palmitate) Extended-release Suspensi - FDA

Description : INVEGA® SUSTENNA® is an atypical antipsychotic. INVEGA® SUSTENNA® contains ...

  • Indications
  • INVEGA® SUSTENNA® (paliperidone palmitate) is indicated for the treatment of schizophrenia. Efficacy was established in four short-term studies and one longer-term stu
  •   Read More
Invega Sustenna (paliperidone palmitate) Extended-release Suspensi - FDA

Description : INVEGA® SUSTENNA® is an atypical antipsychotic. INVEGA® SUSTENNA® contains ...

  • Indications
  • INVEGA® SUSTENNA® (paliperidone palmitate) is indicated for the treatment of schizophrenia. Efficacy was established in four short-term studies and one longer-term stu
  •   Read More
Inversine  mecamylamine (Pronunciation: meck a MILL a meen) - FDA

Description : INVERSINE® (Mecamylamine HCl) is a potent, oral antihypertension agent and ganglion blo...

  • Indications
  • For the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.
  •   Read More
Inversine mecamylamine (Pronunciation: meck a MILL a meen) - FDA

Description : INVERSINE® (Mecamylamine HCl) is a potent, oral antihypertension agent and ganglion&nb...

  • Indications
  • For the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.
  •   Read More
Inversine mecamylamine (Pronunciation: meck a MILL a meen) - Multum

Description : INVERSINE® (Mecamylamine HCl) is a potent, oral antihypertension agent and gangl...

  • Indications
  • For the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension.
  •   Read More
Invirase saquinavir (Pronunciation: sa KWIN a veer - FDA

Description : INVIRASE brand of saquinavir mesylate is an inhibitor of the human immunodeficiency virus t...

  • Indications
  • INVIRASE in combination with ritonavir and other antiretroviral agents is indicated for the treatment of HIV-1 infection in adults (over the age of 16 years). The followi
  •   Read More
Invirase saquinavir (Pronunciation: sa KWIN a veer) - Multum

Description : INVIRASE brand of saquinavir mesylate is an inhibitor of the human immunodeficiency virus t...

  • Indications
  • INVIRASE in combination with ritonavir and other antiretroviral agents is indicated for the treatment of HIV-1 infection in adults (over the age of 16 years). The followi
  •   Read More
Invirase saquinavir (Pronunciation: sa KWIN a veer) - FDA

Description : INVIRASE brand of saquinavir mesylate is an inhibitor of the human immunodeficiency virus type ...

  • Indications
  • INVIRASE in combination with ritonavir and other antiretroviral agents is indicated for the treatment of HIV-1 infection in adults (over the age of 16 years). The following p
  •   Read More
Invirase saquinavir (Pronunciation: sa KWIN a veer) - Multum

Description : INVIRASE brand of saquinavir mesylate is an inhibitor of the human immunodeficiency virus type ...

  • Indications
  • INVIRASE in combination with ritonavir and other antiretroviral agents is indicated for the treatment of HIV-1 infection in adults (over the age of 16 years). The follo
  •   Read More
Invokamet (canagliflozin and metformin hydrochloride) Tablet - FDA

Description : INVOKAMET (canagliflozin and metformin hydrochloride) tablets contain two oral antihypergly...

  • Indications
  • INVOKAMET (canagliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus w
  •   Read More
Invokamet (canagliflozin and metformin hydrochloride) Tablet - FDA

Description : INVOKAMET (canagliflozin and metformin hydrochloride) tablets contain two oral antihypergly...

  • Indications
  • INVOKAMET (canagliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus w
  •   Read More
Invokana (canagliflozin) Film-coated Tablets for Oral Admin - FDA

Description : INVOKANA (canagliflozin) contains canagliflozin, an inhibitor of sodium-glucose co­tran...

  • Indications
  • INDICATIONS INVOKANA® (canagliflozin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinica
  •   Read More
Invokana canagliflozin) Film-coated Tablets for Oral Admini - FDA

Description : INVOKANA (canagliflozin) contains canagliflozin, an inhibitor of sodium-glucose co­tran...

  • Indications
  • INVOKANA® (canagliflozin) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies].
  •   Read More
Ionamin (phentermine resin) Capsules - FDA

Description : IONAMIN '15' and IONAMIN '30' contain 15 mg and 30 mg respectively of phentermine as the ca...

  • Indications
  • IONAMIN Capsules are indicated as a short-term (a few weeks) adjunct in a regimen of weight reduction based on exercise, behavioral modification, and caloric restriction i
  •   Read More
Ionsys fentanyl transdermal (device) (Pronunciation: FEN - FDA

Description : IONSYS™ (fentanyl iontophoretic transdermal system) is a patient-controlled iontophor...

  • Indications
  • IONSYS™ is indicated for the short-term management of acute postoperative pain in adult patients requiring opioid analgesia during hospitalization. Patients should b
  •   Read More
Ionsys fentanyl transdermal (device) (Pronunciation: FEN - Multum

Description : IONSYS™ (fentanyl iontophoretic transdermal system) is a patient-controlled iontophor...

  • Indications
  • IONSYS™ is indicated for the short-term management of acute postoperative pain in adult patients requiring opioid analgesia during hospitalization. Patients should b
  •   Read More
Ionsys fentanyl transdermal (device) (Pronunciation: FEN - FDA

Description : IONSYS™ (fentanyl iontophoretic transdermal system) is a patient-controlled iontophor...

  • Indications
  • IONSYS™ is indicated for the short-term management of acute postoperative pain in adult patients requiring opioid analgesia during hospitalization. Patients should be ti
  •   Read More
Iopidine  apraclonidine ophthalmic (Pronunciation: a pra KL - FDA

Description : IOPIDINE® 0.5% Ophthalmic Solution contains apraclonidine hydrochloride, an alpha adren...

  • Indications
  • IOPIDINE 0.5% Ophthalmic Solution is indicated for short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional IOP reduction. P
  •   Read More
Iopidine Eye apraclonidine ophthalmic (Pronunciation: a pra KLA - FDA

Description : IOPIDINE® 0.5% Ophthalmic Solution contains apraclonidine hydrochloride, an alpha adren...

  • Indications
  • IOPIDINE 0.5% Ophthalmic Solution is indicated for short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional IOP reduction. P
  •   Read More
Iplex mecasermin rinfabate rdna origin injection) (mecas - FDA

Description : IPLEX™ (mecasermin rinfabate rdna origin injection) (mecasermin rinfabate [rDNA origi...

  • Indications
  • IPLEX (mecasermin rinfabate [rDNA origin] injection) is indicated for the treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or wi
  •   Read More
Iplex (mecasermin rinfabate [rDNA origin]) Injection - FDA

Description : IPLEX™ (mecasermin rinfabate rdna origin injection) (mecasermin rinfabate [rDNA origin] i...

  • Indications
  • IPLEX (mecasermin rinfabate [rDNA origin] injection) is indicated for the treatment of growth failure in children with severe primary IGF-1 deficiency (Primary IGFD) or with&n
  •   Read More
Ipol  polio vaccine (IPV) (Pronunciation: POE lee oh - Multum

Description : IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is a sterile susp...

  • Indications
  • IPOL vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Ty
  •   Read More
Ipol polio vaccine (IPV) (Pronunciation: POE lee oh - FDA

Description : IPOL®, Poliovirus Vaccine Inactivated, produced by Sanofi Pasteur SA, is a sterile susp...

  • Indications
  • IPOL vaccine is indicated for active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Ty
  •   Read More
Iprivask (desirudin) for Injection - FDA

Description : Iprivask® (desirudin for injection) is a direct inhibitor of human thrombin. It has a p...

  • Indications
  • Iprivask is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in patients undergoing elective hip replacement surgery.
  •   Read More
Iquix (levofloxacin) Ophthalmic Solution - FDA

Description : IQUIX® (levofloxacin ophthalmic solution) 1.5% is a sterile topical ophthalmic solution...

  • Indications
  • IQUIX® solution is indicated for the treatment of corneal ulcer caused by susceptible strains of the following bacteria: Gram-positive Bacteria Corynebacterium speci
  •   Read More
Iquix levofloxacin) Ophthalmic Solution - FDA

Description : IQUIX® (levofloxacin ophthalmic solution) 1.5% is a sterile topical ophthalmic solution...

  • Indications
  • IQUIX® solution is indicated for the treatment of corneal ulcer caused by susceptible strains of the following bacteria: Gram-positive Bacteria Corynebacterium speci
  •   Read More
Isentress raltegravir (Pronunciation: ral TEG ra veer) - FDA

Description : ISENTRESS contains raltegravir potassium, a human immunodeficiency virus integrase strand t...

  • Indications
  • ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age
  •   Read More
Isentress raltegravir (Pronunciation: ral TEG ra veer) - FDA

Description : ISENTRESS contains raltegravir potassium, a human immunodeficiency virus integrase strand t...

  • Indications
  • ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age
  •   Read More
Isentress raltegravir (Pronunciation: ral TEG ra veer) - Multum

Description : ISENTRESS contains raltegravir potassium, a human immunodeficiency virus integrase strand t...

  • Indications
  • ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age
  •   Read More
Ismelin guanethidine monosulfate - FDA

Description : Ismelin, guanethidine monosulfate USP, is an antihypertensive, available as tablets of 10 m...

  • Indications
  • Ismelin (guanethidine monosulfate) is indicated for the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypert
  •   Read More
Ismelin guanethidine monosulfate - FDA

Description : Ismelin, guanethidine monosulfate USP, is an antihypertensive, available as tablets of 10 m...

  • Indications
  • Ismelin (guanethidine monosulfate) is indicated for the treatment of moderate and severe hypertension, either alone or as an adjunct, and for the treatment of renal hypert
  •   Read More
Isoniazid Tablets (isoniazid) Tablets, USP - FDA

Description : Isoniazid is an antibacterial available as 100 mg and 300 mg tablets for oral administratio...

  • Indications
  • Isoniazid is recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tube
  •   Read More
Isoniazid Tablets isoniazid (Pronunciation: eye so NYE a zid) - Multum

Description : Isoniazid is an antibacterial available as 100 mg and 300 mg tablets for oral administratio...

  • Indications
  • Isoniazid is recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tube
  •   Read More
Isoniazid Tablets Isoniazid - Multum

Description : Isoniazid is an antibacterial available as 100 mg and 300 mg tablets for oral administratio...

  • Indications
  • Isoniazid is recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tube
  •   Read More
Isopto Carpine pilocarpine hydrochloride) Ophthalmic Solution 1%, - FDA

Description : Isopto® Carpine (pilocarpine hydrochloride ophthalmic solution) is a cholinergic agonis...

  • Indications
  • Open-Angle Glaucoma or Ocular Hypertension Isopto® Carpine (pilocarpine) ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in
  •   Read More
Isopto Carpine Isopto® Carpine (pilocarpine hydrochloride) Ophth - FDA

Description : Isopto® Carpine (pilocarpine hydrochloride ophthalmic solution) is a cholinergic agonis...

  • Indications
  • Open-Angle Glaucoma or Ocular Hypertension Isopto® Carpine (pilocarpine) ophthalmic solution is indicated for the reduction of elevated intraocular pressure (IOP) in
  •   Read More
Isopto Hyoscine scopolamine ophthalmic (Pronunciation: skoe POL a - FDA

Description : ISOPTO® HYOSCINE (Scopolamine Hydrobromide) is an anticholinergic prepared as a sterile...

  • Indications
  • For mydriasis and cycloplegia in diagnostic procedures. For some pre- and postoperative states when a mydriatic and cycloplegic is needed in treatment of iridocyclitis.
  •   Read More
Isopto Hyoscine scopolamine ophthalmic (Pronunciation: skoe POL a - FDA

Description : ISOPTO® HYOSCINE (Scopolamine Hydrobromide) is an anticholinergicprepared as a st...

  • Indications
  • For mydriasis and cycloplegia in diagnostic procedures. For some pre- andpostoperative states when a mydriatic and cycloplegic is needed in treatment of iridocy
  •   Read More
Isopto Hyoscine scopolamine ophthalmic (Pronunciation: skoe POL a - Multum

Description : ISOPTO® HYOSCINE (Scopolamine Hydrobromide) is an anticholinergicprepared a...

  • Indications
  • For mydriasis and cycloplegia in diagnostic procedures. For some pre- andpostoperative states when a mydriatic and cycloplegic is needed in treatment of iridocy
  •   Read More
Isovue-M ISOVUE-M® 200 (iopamidol) Injection 41% ISOVUE-M - FDA

Description : ISOVUE-M (lopamidol Injection) formulations are stable, aqueous, sterile, and nonpyrogenic ...

  • Indications
  • ISOVUE-M (lopamidol Injection) is indicated for intrathecal administration in adult neuroradiology including myelography (lumbar, thoracic, cervical, total columnar), and for
  •   Read More
Isovue-M ISOVUE-M® 200 (iopamidol) Injection 41% ISOVUE-M - FDA

Description : ISOVUE-M (lopamidol Injection) formulations are stable, aqueous, sterile, and nonpyrogenic ...

  • Indications
  • ISOVUE-M (lopamidol Injection) is indicated for intrathecal administration in adult neuroradiology including myelography (lumbar, thoracic, cervical, total columnar), and
  •   Read More
Istodax romidepsin (Pronunciation: ROE mi DEP sin - FDA

Description : Romidepsin, a histone deacetylase (HDAC) inhibitor, is a bicyclic depsipeptide. At room tem...

  • Indications
  • ISTODAX is indicated for: Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. Treatment of peripheral T-ce
  •   Read More
Istodax romidepsin (Pronunciation: ROE mi DEP sin) - Multum

Description : Romidepsin, a histone deacetylase (HDAC) inhibitor, is a bicyclic depsipeptide. At room tem...

  • Indications
  • ISTODAX is indicated for: Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. Treatment of peripheral T-ce
  •   Read More
Istodax romidepsin (Pronunciation: ROE mi DEP sin) - FDA

Description : Romidepsin, a histone deacetylase (HDAC) inhibitor, is a bicyclic depsipeptide. At room tem...

  • Indications
  • ISTODAX is indicated for: Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. Treatment of peripheral T-ce
  •   Read More
Istodax romidepsin (Pronunciation: ROE mi DEP sin) - Multum

Description : Romidepsin, a histone deacetylase (HDAC) inhibitor, is a bicyclic depsipeptide. At room tem...

  • Indications
  • ISTODAX is indicated for: Treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy. Treatment of peripheral T-ce
  •   Read More
Isuprel Mistometer isoproterenol inhalation (Pronunciation: eye so pr - FDA

Description : Isoproterenol hydrochloride is 3,4-Dihydroxy-α-[(isopropylamino)methyl] benzyl alcoho...

  • Indications
  • Isoproterenol hydrochloride injection is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. For serious
  •   Read More
Isuprel Mistometer isoproterenol inhalation (Pronunciation: eye so pr - Multum

Description : Isoproterenol hydrochloride is 3,4-Dihydroxy-α-[(isopropylamino)methyl] benzyl alcoho...

  • Indications
  • Isoproterenol hydrochloride injection is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. For serious
  •   Read More
Isuprel Mistometer isoproterenol inhalation (Pronunciation: eye so pr - Multum

Description : Isoproterenol hydrochloride is 3,4-Dihydroxy-α-[(isopropylamino)methyl] benzyl alcoho...

  • Indications
  • Isoproterenol hydrochloride injection is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. For serious
  •   Read More
Ixempra ixabepilone (Pronunciation: IX ab EP i lone) - FDA

Description : IXEMPRA (ixabepilone) is a microtubule inhibitor belonging to a class of antineoplastic age...

  • Indications
  • IXEMPRA (ixabepilone) is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment
  •   Read More
Ixempra ixabepilone (Pronunciation: IX ab EP i lone) - Multum

Description : IXEMPRA (ixabepilone) is a microtubule inhibitor belonging to a class of antineoplastic age...

  • Indications
  • IXEMPRA (ixabepilone) is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment
  •   Read More
Ixempra ixabepilone (Pronunciation: IX ab EP i lone) - Multum

Description : IXEMPRA (ixabepilone) is a microtubule inhibitor belonging to a class of antineoplastic age...

  • Indications
  • IXEMPRA (ixabepilone) is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment
  •   Read More
Ixiaro  Japanese encephalitis virus vaccine SA14-14-2 (Pr - FDA

Description : IXIARO, Japanese Encephalitis Vaccine, Inactivated, Adsorbed is a sterile suspension for intram...

  • Indications
  • IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older.
  •   Read More
Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsor - FDA

Description : IXIARO, Japanese Encephalitis Vaccine, Inactivated, Adsorbed is a sterile suspension for in...

  • Indications
  • IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and olde
  •   Read More
Ixiaro Japanese encephalitis virus vaccine SA14-14-2 - Multum

Description : IXIARO, Japanese Encephalitis Vaccine, Inactivated, Adsorbed is a sterile suspension for in...

  • Indications
  • IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older.
  •   Read More
Izba (travoprost) Ophthalmic Solution - FDA

Description : Travoprost is a synthetic prostaglandin F2α analog. Its chemical name is [1R-[1 (Z),2...

  • Indications
  • IZBA (travoprost ophthalmic solution) 0.003% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  •   Read More
Rx Scoops
Featured Topics
Advertisements
Copyrights ©2014: Rx Scoops - Designed & Developed By - GOIGI